Endocrine Society recommends policies to lower costs for people with diabetes WASHINGTON–Spiraling insulin costs have created a dangerous barrier for many people with diabetes who need to access lifesaving treatments. The Endocrine Society is calling on stakeholders across the supply chain to help reduce out-of-pocket costs for people with diabetes. More information about the factors driving cost increases is needed to effectively combat the trend, the Endocrine Society said...